Tattoos Clinical Trial - Clinical Evaluation of 755nm Alexandrite Laser

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Tattoos

See also
Status	Clinical Trial	Phase
Completed	`NCT02297321` - Evaluation of the Safety and Efficacy of the DeScribe™ Patch	N/A
Completed	`NCT00580736` - Optical Clearing of the Skin in Conjunction With Laser Treatments	Phase 1
Completed	`NCT00540566` - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed	`NCT01754207` - Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02297321 - Evaluation of the Safety and Efficacy of the DeScribe™ Patch

N/A

Completed

NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments

Phase 1

Completed

NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment

Completed

NCT01754207 - Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01811017
Study type	Interventional
Source	Cynosure, Inc.
Contact
Status	Withdrawn
Phase	N/A
Start date	June 2012
Completion date	May 2013

Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm Alexandrite

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms